BRAF and neoplasm: The results of our study show a lack of association of the BRAF mutation status with gender (χ2 = 1.2859; p = 0.257), tumor size (Mann–Whitney U test; U = 2890.5, Z = −1.69, p = 0.09), extrathyroidal expansion (χ2 (1, N = 164) = 0.028; p = 0.866), capsule infiltration (χ2 (1, N = 167) = 0.373; p = 0.541), or dissemination within the thyroid gland (χ2 (1, N = 169) = 0.614; p = 0.433).